Bioinformatics analysis showed that GABRP was significantly overexpressed in a variety of cancers (such as glioma and breast cancer) and was closely associated with a shortened overall survival of patients (TCGA cohort) and an immunosuppressive microenvironment (enrichment of Tregs and M2 macrophages). Here, GABRP is linked to breast carcinoma.